CTIM-14. RESULTS OF PHASE II STUDY OF NIVOLUMAB FOR PATIENTS WITH MENINGIOMAS REFRACTORY TO SURGERY AND RADIOTHERAPY BASED ON IMMUNE-RELATED RESPONSE CRITERIA WITH MOLECULAR ANALYSES
CTIM-14. 基于免疫相关反应标准和分子分析的纳武利尤单抗治疗对手术和放射治疗无效的脑膜瘤患者的II期研究结果
期刊:Therapeutic Advances in Neurological Disorders
影响因子:4.1
doi:10.1177/17562864251405202
Allen, Jeffrey A; Querol, Luis; Suresh, Niraja; Remmerie, Anneleen; Mole, Trevor; McCoy, Kelly; Butler, Lisa; van Hoorick, Benjamin; Kuwabara, Satoshi; van Doorn, Pieter A; Lewis, Richard A; Nelles, Gereon; Bicu, Felix; Weil, Valentina; Steinmann, Tiemo; Stein, Doron Benjamin; Bicu, Alicia; Quante, Arnim; Polidori, Maria Cristina; Oreskovic, T; Kujundzic TIljak, M; Diaz, Esperanza; Gimeno-Feliu, Luis Andrés; Czapka, Elzbieta; Suurmond, Jeanine; Razum, Oliver; Kumar, Bernadette; Sasaki, Hikaru; Takimoto, Tetsuya; Takemura, Ryo; Nakamura, Kohei; Kawano, Ryutaro; Yamaguchi, Shigeru; Adachi, Kazuhide; Kanamori, Masayuki; Kuga, Daisuke; Kamamoto, Dai; Nakaya, Masato; Hino, Utaro; Fujiwara, Hirokazu; Miwa, Tomoru; Nishihara, Hiroshi; Saya, Hideyuki; Kawakami, Yutaka
